S. 932

Status: In committee

Give Kids a Chance Act of 2025

Give Kids a Chance Act of 2025

Sponsored by Markwayne Mullin

Topics

Cosponsors

20

Actions

2

Roll calls

0

Amendments

0

Related bills

5

Actions

Mar 11, 2025 · Library of Congress

Introduced in Senate

Mar 11, 2025 · Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Latest activity

July 2026

Lobbying reported · Stealth Biotherapeutics · Jul 20

Stealth Biotherapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Stealth Biotherapeutics — $120,000

BillsH.R. 1262 H.R. 4121 H.R. 4709 H.R. 6280 S. 932 S. 2256 S. 3607

Lobbying reported · National Association Of Childrens Hospitals And Affiliates · Jul 20

National Association Of Childrens Hospitals And Affiliates reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association Of Children's Hospitals — $1,370,000

BillsH.R. 169 H.R. 1262 H.R. 1509 H.R. 1735 H.R. 2483 H.R. 2587 H.R. 3505 H.R. 3890 H.R. 4768 H.R. 4798 H.R. 5582 H.R. 6396 S. 357 S. 752 S. 932 S. 2355 S. 2448

Lobbying reported · Tourette Association Of America · Jul 20

Tourette Association Of America reported 2nd Quarter (Apr 1 - June 30) lobbying for Tourette Association Of America — $60,000

BillsH.R. 1262 H.R. 3514 H.R. 4206 H.R. 5304 H.R. 5509 H.R. 7148 H.R. 9260 S. 932 S. 1261 S. 1816 S. 2587 S. 2903

Lobbying reported · Novartis · Jul 20

Novartis reported 2nd Quarter (Apr 1 - June 30) lobbying for Novartis — $1,410,000

Lobbying reported · Acadia Pharmaceuticals · Jul 20

Acadia Pharmaceuticals reported 2nd Quarter (Apr 1 - June 30) lobbying for Acadia Pharmaceuticals — $700,000

BillsH.R. 1 H.R. 1262 H.R. 1414 H.R. 1492 H.R. 1509 H.R. 3731 H.R. 6130 H.R. 9102 S. 752 S. 832 S. 932 S. 3267

Lobbying reported · Travere Therapeutics · Jul 20

Travere Therapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Travere Therapeutics — $140,000

BillsH.R. 1 H.R. 1262 H.R. 1414 H.R. 1518 H.R. 4709 H.R. 9102 S. 932 S. 1040 S. 2658

Lobbying reported · The Kpm Group DC · Jul 19

The Kpm Group DC reported 2nd Quarter (Apr 1 - June 30) lobbying for Praxis Precision Medicines — $40,000

BillsH.R. 1262 H.R. 1509 S. 752 S. 932

Lobbying reported · Smithbucklin · Jul 17

Smithbucklin reported 2nd Quarter (Apr 1 - June 30) lobbying for Astct — $70,000

BillsH.R. 1262 H.R. 2491 H.R. 3521 H.R. 5160 S. 932 S. 1227 S. 4109 S. 4440

Lobbying reported · Ionis Pharmaceuticals · Jul 17

Ionis Pharmaceuticals reported 2nd Quarter (Apr 1 - June 30) lobbying for Ionis Pharmaceuticals — $150,000

BillsH.R. 1262 H.R. 1414 H.R. 1672 S. 932

Lobbying reported · Bridgebio Pharma · Jul 17

Bridgebio Pharma reported 4th Quarter (Oct 1 - Dec 31) lobbying for Bridgebio Pharma — $280,000

BillsH.R. 1 H.R. 1262 S. 932

Lobbying reported · Bracewell · Jul 16

Bracewell reported 2nd Quarter (Apr 1 - June 30) lobbying for Aquestive Therapeutics — $60,000

BillsH.R. 1262 S. 932

Lobbying reported · Roberti Global · Jul 16

Roberti Global reported 2nd Quarter (Apr 1 - June 30) lobbying for Biotechnology Innovation Organization — $60,000

BillsH.R. 1262 S. 932 S. 2296

Lobbying reported · Nationwide Children's Hospital · Jul 15

Nationwide Children's Hospital reported 2nd Quarter (Apr 1 - June 30) lobbying for Nationwide Children's Hospital — $80,000

BillsH.R. 1 H.R. 1262 H.R. 3277 H.R. 3302 H.R. 5304 H.R. 5371 H.R. 5582 H.R. 7148 H.R. 9504 H.R. 9599 S. 891 S. 932 S. 1677 S. 2355 S. 2587 S. 3389

Lobbying reported · Healthcare Institute Of New Jersey · Jul 15

Healthcare Institute Of New Jersey reported 2nd Quarter (Apr 1 - June 30) lobbying for Healthcare Institute Of New Jersey — $47,670

BillsH.R. 1262 H.R. 1414 H.R. 1492 H.R. 1672 H.R. 2369 H.R. 2377 H.R. 2940 H.R. 5269 H.R. 5391 H.R. 6283 S. 832 S. 932 S. 2761 S. 3549

You’re all caught up.